Revenue of $2.86 puts us at $11.44m annualised with plenty of upside from here. IMO we are on target, I'm not expecting a huge share price rise tomorrow, but a little kick for now.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game